『GOG GYN-LIVE』のカバーアート

GOG GYN-LIVE

GOG GYN-LIVE

著者： The GOG Foundation Inc.
無料で聴く

今ならプレミアムプランが3カ月 月額99円

2026年5月12日まで。4か月目以降は月額1,500円で自動更新します。

概要

 Welcome to the official podcast of The GOG Foundation, Inc.—a nonprofit organization dedicated to advancing excellence in clinical and scientific research for gynecologic cancers. From ovarian and uterine to cervical, vaginal, and vulvar malignancies, our investigators and institutions are at the forefront of innovation, shaping the future of cancer care. Each episode features leading experts, groundbreaking trial insights, and real-world stories that illuminate the evolving landscape of gynecologic oncology. Whether you're a clinician, researcher, patient advocate, or survivor, join us as we explore the science, the people, and the progress driving better outcomes and quality of life for patients everywhere.© 2026 The GOG Foundation, Inc. マネジメント マネジメント・リーダーシップ 経済学 衛生・健康的な生活 身体的病い・疾患
エピソード
  • Accrual Culture: Top Points for Site Selection - Timelines

    Accrual Culture: Top Points for Site Selection - Timelines
    2026/04/02

    The GOG Foundation, Inc. would like to thank our commercial supporters for their support of the GOG GYN-LIVE Podcast:
    Corcept Therapeutics, GSK, Pfizer Oncology, Eli Lilly, Genmab, and Verastem

    ★ Support this podcast ★
    続きを読む 一部表示
    21 分
  • Accrual Culture: Top Points for Site Selection - Responsiveness

    Accrual Culture: Top Points for Site Selection - Responsiveness
    2026/03/06
    18 分
  • GOG-3101 | TroFuse-20 Clinical Trial Update

    GOG-3101 | TroFuse-20 Clinical Trial Update
    2026/03/05

    In this episode, we dive into GOG‑3101 TroFuse‑20—a Phase 3, randomized, active‑controlled, open‑label, multicenter study evaluating MK‑2870 monotherapy versus Treatment of Physician’s Choice as second‑ or third‑line therapy for patients with recurrent or metastatic cervical cancer.

    ★ Support this podcast ★
    続きを読む 一部表示
    13 分
まだレビューはありません